Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment interventions for patients with rare or very rare cancers or cancer subtypes
Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes: Patients with rare or very rare cancers or cancer subtypes have access to tailored, promising biomarker-guided medicines or multi-modal treatment interventions via participation in subsequent clinical trials or national or regional compassionate use programmes by…
Funding and competition
- 3grants expected (official)
- €7M–€9MEU contribution per project
- €7.2Mmedian EU grant of the most similar funded projects
- 67projects funded in earlier topics of this programme line
Success rates vary widely between topics (often from below 5% to above 30%). Ask us for the success-rate history of this topic before you commit to a proposal.
Organisations with a track record in this topic
Organisations that took part in the EU-funded projects most similar to this call (Horizon Europe and Horizon 2020), ranked by how close those projects are to the call, how recent they are and whether the organisation coordinated them. Being listed does not mean an organisation is looking for partners: use the list to target your outreach.
Spanish organisations with experience in this field
The Spanish organisations that appear most often in the closest funded projects.
What a typical winning consortium looks like
- 19partners (median)
- 9countries (median)
- 12%of partners are SMEs
Based on the 25 funded projects closest to this call. Use it as a benchmark, not a rule: always check the call conditions for the minimum consortium.
Most similar funded projects
Read their CORDIS pages to see the full consortium, results and deliverables.
- EU-CIP – EUropean Cancer Information Portal (HORIZON · 2025 · HORIZON-MISS-2024-CANCER-01-06)
- IDEA4RC – Intelligent Ecosystem to improve the governance, the sharing and the re-use of health Data for Rare Cancers (HORIZON · 2022 · HORIZON-HLTH-2021-TOOL-06-03)
- PRIME-ROSE – PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials (HORIZON · 2023 · HORIZON-MISS-2022-CANCER-01-03)
- TAIST – Tumour activated immunotherapy for solid tumours (taist) (HORIZON · 2026 · HORIZON-HLTH-2025-01-TOOL-05)
- DEFINITIVE – Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer (HORIZON · 2023 · HORIZON-MISS-2023-CANCER-01-03)
- ENACT-65 – ENabling ACTion on Integrated Nutritional and Exercise Care in Cancer – for Patients 65 and Beyond (HORIZON · 2026 · HORIZON-MISS-2025-02-CANCER-05)
Live partner requests
Organisations actively looking for partners publish their requests on these official platforms.
Partner search on this topic
On the official topic page, open “Partner search announcements” to see organisations that have declared interest in this exact topic, or publish your own (EU Login required).
Open the topic ↗Health NCP Net
Network of Health National Contact Points: partner search, brokerage events and proposal support for Cluster 1 Health and IHI.
Open ↗EU Funding & Tenders Partner Search
Search all organisations registered in the portal by keyword, programme, country and organisation type.
Search organisations ↗Enterprise Europe Network
Europe's largest database of business, technology and R&D cooperation requests. Filter by “Research and development request”.
Browse requests ↗Upcoming info days and brokerage events
Brokerage events are where most consortia are built.
- 10 Nov 2026 · European Research and Innovation Days 2026 (Brussels and online)
- 24 Nov 2026 · Horizon Europe Cluster 1 Health brokerage event (Online)
- 25 Nov 2026 · Bridges Health: training and matchmaking for Horizon Europe consortia (Thessaloniki, Greece)
- 26 Nov 2026 · Horizon Europe Cluster 1 Health Info Day (Online)
- 1 Dec 2026 · Interdisciplinary Pathways towards Green and Resilient Societies (Online)
Publish what you are looking for or what you can offer on the Ullswater partner board. We review each request, publish it on this page and introduce you to suitable partners.
Track-record data: CORDIS open data (European Commission), organisation level only, refreshed weekly. Rankings are calculated automatically by Ullswater Investments from text similarity between the call and funded projects; they are indicative.